Tissue distribution of 20 nm, 100 nm and 1000 nm fluorescent polystyrene latex nanospheres following acute systemic or acute and repeat airway exposure in the rat

被引:70
作者
Sarlo, Katherine [1 ]
Blackburn, Karen L.
Clark, Edwin D. [2 ]
Grothaus, Jeff
Chaney, Joel
Neu, Suzanne [3 ]
Flood, Janine
Abbott, Dana
Bohne, Clarence
Casey, Keith
Fryer, Charles
Kuhn, Mike
机构
[1] Procter & Gamble Co, Miami Valley Innovat Ctr, Cincinnati, OH 45253 USA
[2] Essential Immunotox Serv, Harrison, OH 45030 USA
[3] VetPathServices, Mason, OH 45040 USA
关键词
Nanoparticles; Toxicokinetics; Tissue distribution; INHALATION EXPOSURE; PARTICLES; NANOPARTICLES; PHARMACOKINETICS; TRANSLOCATION; CIRCULATION; CLEARANCE; LUNG;
D O I
10.1016/j.tox.2009.07.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Understanding tissue distribution and clearance of nanomaterials following different routes of exposure is needed for risk assessment. F344 female rats received single or multiple exposures to 20 nm, 100 nm or 1000 nm latex fluorospheres by intravenous (i.v.) injection or oral pharyngeal aspiration into the airways. The presence of fluorospheres in tissues was assessed up to 90-120 days after the final dose. Blood, perfusion fluid, bone marrow, brain, eyes, feces, gut, heart, kidney, liver, lung, muscle, skin, spleen, thymus, tongue, urine and uterus plus ovaries were collected for analysis. Liver, spleen and lung were the greatest tissue depots for all particles following i.v. injection. The proportion of 100 nm and 1000 nm but not 20 nm spheres significantly increased in the spleen over time. Lung was the greatest tissue depot for all particles following single or repeat airway exposure. Greater than 95% of 1000 nm spheres that were recovered were in the lung in contrast to 70-80% of 20 nm spheres or 89-95% of 100 nm spheres. All 3 sizes were found in gut or gut+feces 1-7 days after lung exposure. The thymus was the largest extra-pulmonary depot for the particles; up to 25% of recovered 20 nm particles were in the thymus up to 4 months after exposure compared to 6% of 100 nm particles and 1-3% of 1000 nm particles. A small proportion of 20 nm particles were detected in kidney following both acute and repeat airway exposure. Low numbers of particles were found in the circulation (blood, perfusion), bone marrow, brain, heart, liver and spleen but not in eye, muscle, skin, tongue, ovaries, uterus or urine. These data show that the tissue targets of nano-and micron-sized spheres are very similar whether exposure occurs systemically or via the airways while the proportion of particles in some tissues and tissue clearance varies based on particle size. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 23 条
[1]   INTRATHORACIC DISTRIBUTION AND TRANSPORT OF AEROSOLIZED SILICA IN THE RAT [J].
ABSHER, MP ;
HEMENWAY, DR ;
LESLIE, KO ;
TROMBLEY, L ;
VACEK, P .
EXPERIMENTAL LUNG RESEARCH, 1992, 18 (05) :743-757
[2]   Polystyrene microspheres as a specific marker for the diagnosis of aspiration in hamsters [J].
Avital, A ;
Shapiro, E ;
Doviner, V ;
Sherman, Y ;
Margel, S ;
Tsuberi, M ;
Springer, C .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 27 (04) :511-514
[3]   Size-dependent proinflammatory effects of ultrafine polystyrene particles: A role for surface area and oxidative stress in the enhanced activity of ultrafines [J].
Brown, DM ;
Wilson, MR ;
MacNee, W ;
Stone, V ;
Donaldson, K .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 175 (03) :191-199
[4]  
*CHARL RIV, 1984, BAS HEM CLIN CHEM VA
[5]  
EGGLI P, 1986, THYMUS, V8, P129
[6]   Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats [J].
Fabian, Eric ;
Landsiedel, Robert ;
Ma-Hock, Lan ;
Wiench, Karin ;
Wohlleben, Wendel ;
van Ravenzwaay, Ben .
ARCHIVES OF TOXICOLOGY, 2008, 82 (03) :151-157
[7]   Pharmacokinetics of nanoscale quantum dots: In vivo distribution, sequestration, and clearance in the rat [J].
Fischer, Hans C. ;
Liu, Lichuan ;
Pang, K. Sandy ;
Chan, Warren C. W. .
ADVANCED FUNCTIONAL MATERIALS, 2006, 16 (10) :1299-1305
[8]   Nanofabricated particles for engineered drug therapies:: A preliminary Biodistribution study of PRINT ™ nanoparticles [J].
Gratton, Stephanie E. A. ;
PohhauS, Patrick D. ;
Lee, Jin ;
Guo, Ii ;
Cho, Moo J. ;
DeSimone, Joseph M. .
JOURNAL OF CONTROLLED RELEASE, 2007, 121 (1-2) :10-18
[9]   Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats [J].
Jain, Tapan K. ;
Reddy, Maram K. ;
Morales, Marco A. ;
Leslie-Pelecky, Diandra L. ;
Labhasetwar, Vinod .
MOLECULAR PHARMACEUTICS, 2008, 5 (02) :316-327
[10]  
KEARNS P, 2009, SAFETY NANOTECHNOLOG, P351